Sign in
8-K

Current Report

Werewolf Therapeutics, Inc. Filed Acc 0001193125-22-106804

Material agreement · New debt or obligation · Executive or director change

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.03 Creation of a direct financial obligation
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading d349792d8k.htm…